Ruth Broering

researcher

Born 1977-01-01

Ruth Broering is …
instance of (P31):
humanQ5

External links are
P13049DDB person (GND) ID135613841
P227GND ID135613841
P213ISNI0000000019584609
P496ORCID iD0000-0002-7125-3246
P214VIAF cluster ID57834479

P69educated atUniversity of OldenburgQ597758
P108employerUniversity of Duisburg-EssenQ696757
P735given nameRuthQ18014868
RuthQ18014868
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q40409310Advanced Method for Isolation of Mouse Hepatocytes, Liver Sinusoidal Endothelial Cells, and Kupffer Cells.
Q35788567All-In-One: Advanced preparation of Human Parenchymal and Non-Parenchymal Liver Cells
Q36607038B cells in chronically hepatitis C virus-infected individuals lack a virus-induced mutation signature in the TP53, CTNNB1, and BCL6 genes
Q97429385Controversial: Early Innate Responses to Hepatitis B Virus Infection, an Explanation for Viral Persistence?
Q57079480Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state
Q37716774Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control during Antiviral Therapy
Q40034662Hepatic expression of proteasome subunit alpha type-6 is upregulated during viral hepatitis and putatively regulates the expression of ISG15 ubiquitin-like modifier, a proviral host gene in hepatitis C virus infection.
Q92568797Hepatitis B virus particles activate toll-like receptor 2 signaling initial upon infection of primary human hepatocytes
Q112611670Hippo Pathway Counter-Regulates Innate Immunity in Hepatitis B Virus Infection
Q39035030Identification of proteins that mediate the pro-viral functions of the interferon stimulated gene 15 in hepatitis C virus replication
Q40251263Inducible Rubicon facilitates viral replication by antagonizing interferon production
Q42232853Intrahepatic B-cell follicles of chronically hepatitis C virus-infected individuals lack signs of an ectopic germinal center reaction.
Q42221479KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs.
Q91408439Major Vault Protein Promotes Hepatocellular Carcinoma Through Targeting Interferon Regulatory Factor 2 and Decreasing p53 Activity
Q39281058MicroRNA-155 controls Toll-like receptor 3- and hepatitis C virus-induced immune responses in the liver.
Q38011249Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections.
Q57178052Recent advances in the discovery and development of TLR ligands as novel therapeutics for chronic HBV and HIV infections
Q44644460Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
Q37907346Role of Toll-like receptors in liver health and disease
Q38909782Set7 facilitates hepatitis C virus replication via enzymatic activity-dependent attenuation of the IFN-related pathway.
Q92124247Sofosbuvir Activates EGFR-Dependent Pathways in Hepatoma Cells with Implications for Liver-Related Pathological Processes
Q49832770TLR2 Stimulation Strengthens Intrahepatic Myeloid-Derived Cell-Mediated T Cell Tolerance through Inducing Kupffer Cell Expansion and IL-10 Production
Q39855775The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response.
Q35839139Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection
Q39806543Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication.
Q57079491Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice
Q39999219Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication.

Search more.